Journal Information
Vol. 34. Issue 9.
Pages 453-462 (October 1998)
Share
Share
Download PDF
More article options
Vol. 34. Issue 9.
Pages 453-462 (October 1998)
Full text access
Infección y enfermedad pulmonar obstructiva crónica
Visits
3251
R. Zalacain*
Servicio de Neumología. Hospital de Cruces. Vizcaya
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
R. Zalacain.
Antibioterapia en la reagudización de la EPOC En: Actualizaciones SEPAR.
Prous Editores, (1995), pp. 61-76
[2.]
American Thoracic Society.
Standards for the diagnosis and care of patients with chronic obstructivo pulmonary disease (COPD) and asthma.
Am Rev Respir Dis, 136 (1987), pp. 225-244
[3.]
I. Tager, F.E. Speizer.
Role of infection in chronic bronchitis.
N Engí J Med., 292 (1975), pp. 563-571
[4.]
Antibiotics for exacerbations of chronic bronchitis [editorial]. Lancet 1987: 2: 23-24.
[5.]
S. Chodosh.
Acute bacterial exacerbations in bronchitis and asthma.
Am J Med, 82 (1987), pp. 154-163
[6.]
M.B. Nicotra, M. Rivera.
Chronic bronchitis: when and how to treat?.
Semin Respir Infect, 3 (1988), pp. 61-71
[7.]
T. Montemayor, I. Altajeme, C. Escudero, J. Morera, L. Sánchez Agudo.
Normativa sobre diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol, 32 (1996), pp. 285-301
[8.]
B.R. Celli, G.L. Snider, J. Heffner, B. Tiep, I. Ziment, B. Make, et al.
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 152 (1995), pp. 77-120
[9.]
N.M. Siafakas, P. Vermiere, N.B. Pride, P. Paoletti, J. Gibson, P. Howard, et al.
Optimal assessment and management of patients with chronic obstructive pulmonary disease (COPD).
Eur Respir J, 8 (1995), pp. 1.398-1.420
[10.]
BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52 (Supl 5): 1-28.
[11.]
C. Jenkins, C. Mitchel, L. Irving, P. Frith, I. Yount.
Guidelines for the management of chronic obstructive pulmonary disease.
Mod Med Aust, 38 (1995), pp. 132-146
[12.]
H.Y. Reynolds.
Lung host defenses: a status report.
Chest, 75 (1979), pp. 239-242
[13.]
M.B. Kirkpatrick, J.B. Bass.
Quantitative bacterial cultures of bronchoalveolar fluid and protected catheter specimens from normal subjects.
Am Rev Respir Dis, 139 (1989), pp. 546-548
[14.]
H.Y. Reynolds.
Host defense impairments that may lead to respiratory infections.
Clin Chest Med, 8 (1987), pp. 339-358
[15.]
L. Van Alphen, H.M. Jansen, J. Dankert.
Virulence factors in the colonization and persistence of bacteria in the airways.
Am J Respir Crit Care Med, 151 (1995), pp. 2.094-2.100
[16.]
T.F. Murphy, S. Sethi.
Bacterial infection in chronic obstructive pulmonary disease.
Am Rev Respir Dis, 146 (1992), pp. 1.067-1.083
[17.]
J.A. Martínez, J. Bugés, E. Rodríguez.
La infección bronquial y su tratamiento en la enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol, 28 (1992), pp. 247-252
[18.]
R. Wilson, R.B. Dowling, A.D. Jackson.
The biology of bacterial colonization and invasion of the respiratory mucosa.
Eur Respir J, 9 (1996), pp. 1.523-1.530
[19.]
R. Wilson.
The pathogenesis and management of bronchial infections: the vicious circle of respiratory decline.
Rev Contemp Pharmacother, 3 (1992), pp. 103-112
[20.]
H.M. Jansen, A.P.E. Sachs, L. Van Alphen.
Predisposing conditions to bacterial infections in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 151 (1995), pp. 2.073-2.080
[21.]
J.S. Elborn, D.J. Shale.
Infections of the airways.
Curr Opin Infect Dis, 5 (1992), pp. 170-175
[22.]
G.C. Riise, S. Larsson, B.A. Andersson.
Bacterial adhesion in bronchial epithelial cells in smokers with chronic bronchitis and in healthy nonsmokers.
Eur Respir J, 7 (1994), pp. 1.759-1.764
[23.]
J.H. Shelhamer, S.J. Levine, T. Wu, W.B. Jacoby, M.A. Kaliner, S.I. Rennard.
NIH conference. Airway inflammation.
Ann Intern Med, 123 (1995), pp. 288-304
[24.]
L.B. Palmer.
Bacterial colonization: pathogenesis and clinical significance.
Clin Chest Med, 8 (1987), pp. 455-466
[25.]
P. Cole.
Host-microbe relationships in chronic respiratory infection.
Respiration, 55 (1989), pp. 5-8
[26.]
G.C. Riise, S. Ahlstedt, S. Larsson, I. Enander, I. Jones, P. Larsson, et al.
Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid.
Thorax, 50 (1995), pp. 360-365
[27.]
P. Howard.
A long-term follow-up of respiratory symptoms and ventilatory function in a group of working men.
Br J Industr Med, 27 (1970), pp. 326-333
[28.]
D.V. Bates.
The fate of the chronic bronchitic: a report of the ten-years follow-up in the Canadian Department of Veteran's Affairs coordinated study of chronic bronchitis.
Am Rev Respir Dis, 108 (1973), pp. 1.043-1.065
[29.]
C. Fletcher, R. Peto.
The natural history of chronic airflow obstruction.
Br Med J, 1 (1977), pp. 1.645-1.648
[30.]
R.E. Kanner, A.D. Renzetti, M.R. Klauber, C.B. Smith, C.A. Golden.
Variables associated with changes in spirometry in patients with obstructive lung diseases.
Am J Med, 67 (1979), pp. 44-50
[31.]
R. Peto, F.E. Speizer, A.L. Cochrane, F. Moore, C.M. Fletcher, C.M. Tinker, et al.
The relevance in adults of airflow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease.
Am Rev Respir Dis, 128 (1983), pp. 491-500
[32.]
E. Prescott, P. Lange, J. Vestbo.
Chronic mucus hypersecretion in COPD and death from pulmonary infection.
Eur Respir J, 8 (1995), pp. 1.333-1.338
[33.]
K. Groneveid, L. Van Alphen, P.P. Eijk, G. Visschers, H.M. Jansen, H.C. Zanen.
Endogenous and exogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence.
J Infect Dis, 161 (1990), pp. 512-517
[34.]
P. Ball.
Epidemiology and treatment of chronic bronchitis and its exacerbations.
Chest, 108 (1995), pp. 43-52
[35.]
R.S. Irwin, A.D. Erickson, M.R. Pratter, W.M. Corrao, M.L. Garrity, J.R. Myers, et al.
Prediction of tracheobronchial colonization in current cigarrete smokers with chronic obstructive bronchitis.
J Infect Dis, 145 (1982), pp. 234-241
[36.]
J. Bjerkestrand, A. Digranes, A. Schreiner.
Bacteriological findings in transtracheal aspirates from patients with chronic bron chitis and bronchiectasias.
Scand J Respir Dis, 56 (1975), pp. 201-207
[37.]
L. Vereen, L.M. Smart, R.B. George.
Antibody coating and quantitative cultures of bacteria in sputum and bronchial brush specimens from patients with stable chronic bronchitis.
Chest, 90 (1986), pp. 534-536
[38.]
G.C. Riise, S. Larsson, P. Larsson, S. Jeansson, B.A. Andersson.
The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy?.
Eur Respir J, 7 (1994), pp. 94-101
[39.]
E. Monsó, J. Ruiz, A. Rosell, J. Manterola, J. Fiz, J. Morera.
Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.
Am J Respir Crit Care Med, 152 (1995), pp. 1.316-1.320
[40.]
R. Zalacain, V. Achótegui, I. Pascal, J. Camino, J. Barrón, V. Sobradillo.
El cepillado protegido bacteriológico en pacientes con EPOC severa.
Arch Bronconeumol, 33 (1997), pp. 16-19
[41.]
H. Cabello, A. Torres, R. Celis, M. El-Ebiary, J. Puig de la Bellacasa, A. Xaubet, et al.
Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopy study.
Eur Respir J, 19 (1997), pp. 1.137-1.144
[42.]
R. Zalacain, I. Pascal, J. Camino, J. Barrón, V. Achótegui, V. Sobradillo.
El cepillado protegido bacteriológico en pacientes con EPOC estable.
Arch Bronconeumol, 33 (1997), pp. 35
[43.]
N.W. Wimberley, J.B. Bass, B.W. Boyd, M.B. Kirkpatrick, R.A. Serio, H.M. Pollock.
Use of a bronchoscopic protected catheter brush for the diagnosis of pulmonary infections.
Chest, 81 (1982), pp. 556-562
[44.]
S. Schllick.
Selective indications for use of antibiotics: when and what?.
Eur Respir Rev, 2 (1992), pp. 187-192
[45.]
R. Harlid, G. Andersson, C.G. Frostell, H.J.A. Jörbeck, A.B. Örtqvist.
Respiratory tract colonization and infection in patients with chronic tracheostomy.
Am J Respir Crit Care Med, 154 (1996), pp. 124-129
[46.]
J.Y. Fagon, J. Chastre, J.L. Trouillet, Y. Domart, M.C. Dombret, M. Bornet, et al.
Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis.
Am Rev Respir Dis, 142 (1990), pp. 1.004-1.008
[47.]
T.J. Marrie, H. Durant, L. Yates.
Community-acquired pneumonía requiring hospitalization: 5-years prospective study.
Rev Infect Dis, 11 (1989), pp. 586-599
[48.]
A. Torres, J. Dorca, R. Zalacain, S. Bello, M. El-Ebiary, L. Molinos, et al.
Community-acquired pneumonia in chronic obstructive pulmonary disease. A Spanish multicenter study.
Am J Respir Crit Care Med, 154 (1996), pp. 1.456-1.461
[49.]
J.P. Derenne, B. Fleury, R. Pariente.
Acute respiratory failure of chronic obstructive pulmonary disease.
Am Rev Respir Dis, 138 (1988), pp. 1.006-1.033
[50.]
R.A. Gleckman.
Bronchial infections: acute bronchitis and acute exacerbations of chronic bronchitis.
Comprehens Ther, 13 (1987), pp. 44-48
[51.]
A.C. Stenhouse.
Viral antibody levels and clinical status in acute exacerbations of chronic bronchitis.
Br Med J, 3 (1968), pp. 287-290
[52.]
N. Reichek, E.B. Lewin, D.L. Rhonden, R.R. Weaver.
Antibody responses to bacterial antigens during exacerbations of chronic bronchitis.
Am Rev Respir Dis, 101 (1970), pp. 238-244
[53.]
M.B. Esdie, E.J. Scott, N.R. Grist.
Virological studies in chronic bronchitis.
Br Med J, 2 (1966), pp. 671-673
[54.]
D.W. Gump, C.A. Philips, B.R. Forsyth, K. Mcintosh, K.R. Lamborn, W.H. Stouch.
Role of infection in chronic bronchitis.
Am Rev Respir Dis, 113 (1976), pp. 465-474
[55.]
R.S. Irwin, W.M. Corrao, A.D. Erickson, M.R. Pratter, F.L. Garrity, J.T. Kaemmerlen.
A true exacerbation of chronic bronchitis can be objectively defmed.
Am Rev Respir Dis, 121 (1980), pp. 151
[56.]
M.B. Nicotra, M. Rivera, R.J. Awe.
Antibiotic therapy of acute exacerbations in chronic bronchitis.
Ann Intern Med, 97 (1982), pp. 18-21
[57.]
N.R. Anthonisen, J. Manfreda, C.P.W. Warren, E.S. Hershfield, G.K.M. Harding, N.A. Nelson.
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
Ann Intern Med, 106 (1987), pp. 196-204
[58.]
J. Dorca.
Acute bronchial infection in chronic obstructive pulmonary disease.
Monaldi Arch Chest Dis, 50 (1995), pp. 366-371
[59.]
L.S. Abussouan.
Acute exacerbations of chronic bronchitis.
Postgr Med, 99 (1996), pp. 89-104
[60.]
J.H. Bates.
The role of infection during exacerbations of chronic bronchitis.
Ann Intem Med, 97 (1982), pp. 130-131
[61.]
S. Sethi, N. Evans, K. Muscarella, K. Klingman, T.F. Murphy.
Sputum induction in stable chronic obstructive pulmonary disease (COPD): effect on sputum bacteriology.
Am J Respir Crit Care Med, 151 (1995), pp. 839
[62.]
C. O’Brien, B. Leung, S.L. Hill, R.A. Stockley.
The nature of exa cerbations of COPD.
Thorax, 52 (1997), pp. 6
[63.]
R. Wilson.
Outcome predictors in bronchitis.
Chest, 108 (1995), pp. 53-57
[64.]
D.C. Taylor, R.L. Clancy, A.W. Cripps, H. Butt, L. Bartlett, K. Murree Allen.
An alteration in the host-parasite relationship in subjects with chronic bronchitis prone to recurrent episodes of acute bronchitis.
Immunol Cell Biol, 72 (1994), pp. 143-151
[65.]
G.W. Hunningkale.
Infection and bronchial hyperreactivity in chronic obstructive pulmonary disease.
Eur Respir Rev, 2 (1992), pp. 166-168
[66.]
G.J. Bartlett.
Diagnostic accuracy of transtracheal aspiration bacteriologic studies.
Am Rev Respir Dis, 115 (1997), pp. 777-782
[67.]
A. Schreinner, G. Bjerkestrand, A. Digranes, F.J. Halversen, T.M. Kommendal.
Bacteriological findings in the transtracheal aspirate from patients with acute exacerbation of chronic bronchitis.
In fection, 6 (1978), pp. 54-56
[68.]
H. Haas, J.F. Morris, S. Samson, K.P. Kilboum, J. Kim.
Bacterial flora of the respiratory tract in chronic bronchitis: comparison of transtracheal, fibrobronchoscopic and oropharyngeal sampling methods.
Am Rev Respir Dis, 116 (1977), pp. 41-47
[69.]
R.S. Irwin, W.M. Corrao, A.D. Erickson, M.R. Pratter, F.L. Garrity, J.T. Kaemmerlen.
Characterization by transtracheal aspiration of the tracheobronchial microflora during exacerbations of chronic bronchitis.
Am Rev Respir Dis, 121 (1980), pp. 150
[70.]
E.L. Spada, A. Tinivella, S. Carli, S. Zaccari, M. Lusuardi, A. Sbaffí, et al.
Proposal of an easy method to improve routine sputum bacteriology.
Respiration, 56 (1989), pp. 137-146
[71.]
H.M. Pollock, E.L. Hawkins, J.R. Bonner, T. Sparkman, J.B. Bass.
Diagnosis of bacterial pulmonary infections with quantitative protected catheter cultures obtained during bronchoscopy.
J Clin Microbiol, 17 (1983), pp. 255-259
[72.]
J.A. Martínez, E. Rodríguez, T. Bastida, J. Bugés, M. Torres.
Quantitative study of the bronchial bacterial flora in acute exacerbations of chronic bronchitis.
Chest, 105 (1994), pp. 976
[73.]
R. Pela, F. Marchesani, L. Cecarini, D. Staccioli, C.M. Sanguinetti.
Which bacteria in bronchial secretions from COPD patients?. A fiberbroncoscopic study.
Eur Respir J, 8 (1995), pp. 1.705
[74.]
N. Soler, R. Celis, A. Torres, J. González, M. El-Ebiary, J. Puig de la Bellacasa, et al.
Papel de la infección bronquial en pacientes con EPOC y exacerbación aguda grave sometidos a ventilación mecánica.
Arch Bronconeumol, 33 (1997), pp. 36
[75.]
Y.J. Fagon, J. Chastre.
Severe exacerbations of COPD patients: the role of pulmonary infections.
Semin Respir Infect, 11 (1996), pp. 109-118
[76.]
J.H. Sportel, G.H. Koëter, R. Van Altena, A. Löwenberg, W.G. Boersma.
Relation between beta-lactamase producing bacteria and patient characteristic in chronic obstructive pulmonary disease (COPD).
Thorax, 50 (1995), pp. 249-253
[77.]
H.K.F. Van Saene, F.T.C. Willems, R.J. Davies.
The abnormal carrier state and superinfection following antibiotic treatment of respiratory tract infection in general practice: a clinical controlled trial.
Eur Respir Rev, 2 (1991), pp. 192-198
[78.]
A.D. Carilli, R.S. Gohs, W. Gordon.
A virologic study of chronic bronchitis.
N Engl J Med, 270 (1964), pp. 123-127
[79.]
J.E. Stark, R.B. Heath, M.P. Curwen.
Infection with influenza and parainfluenza viruses in chronic bronchitis.
Thorax, 20 (1965), pp. 124-127
[80.]
M.A.J. Moffat, J.A.W. Sutherland.
Persistence of viral antibodies in patients with chronic bronchitis.
Br Med J, 1 (1967), pp. 601-603
[81.]
M.J. McNamara, I.A. Phillips, O.B. Williams.
Viral and Mycoplasma pneumoniae infections in exacerbations of chronic lung disease.
Am Rev Respir Dis, 100 (1969), pp. 19-24
[82.]
R.O. Buscho, D. Saxtan, P.S. Shuitz, E. Finch, M.A. Mufson.
Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis.
J Infect Dis, 137 (1978), pp. 377-383
[83.]
F. Philit, J. Etienne, A. Calvet, J.F. Momex, V. Trillet, M. Aymard, et al.
Infectious agents associated with exacerbations of chronic obstructive pulmonary disease and attacks of asthma.
Rev Mal Respir, 9 (1982), pp. 191-196
[84.]
C.F. Donner, M. Lusuardi.
Role of infections and inhalled pollutants in COPD: concluding remarks.
Eur Respir Rev, 2 (1992), pp. 208-211
[85.]
A.C. Shaw.
Serum C-reactive protein and neopterin concentrations in patients with viral or bacterial infection.
J Clin Pathol, 44 (1991), pp. 596-599
[86.]
C.B. Smith, C.A. Golden, R.E. Kanner, A.D. Renzetti.
Association of viral and Mycoplasmu pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis, 121 (1980), pp. 225-232
[87.]
F. Blasi, D. Legnani, V.M. Lombardo, G.G. Negretto, E. Magliano, R. Pozzoli, et al.
Chlamydia pneumoniae infection in acute exacerbations of chronic bronchitis.
Eur Respir J, 6 (1993), pp. 19-22
[88.]
J.T. Grayston, M.B. Aldous, A. Easton, S.P. Wang, C.C. Kuo, L.A. Camp bell.
Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis.
J Infect Dis, 168 (1993), pp. 1.231-1.235
[89.]
S. Bello.
Clamidias y patología respiratoria.
Arch Bronconeumol, 33 (1997), pp. 527-540
[90.]
L. Von Hertzen, R. Isoaho, M. Leinonen, R. Koskinen, P. Laippola, M. Toyryla, et al.
Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease.
Int J Epidemiol, 25 (1996), pp. 658-664
[91.]
J.T. McFarlane, A. Colville, A. Guion, R.M. McFarlane, D.H. Rose.
Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community.
Lancet, 341 (1993), pp. 511-514
[92.]
P. Ball, J.M. Harris, D. Lowson, G. Tillotson, R. Wilson.
Acute infective exacerbations of chronic bronchitis.
Q J Med, 88 (1995), pp. 61-68
[93.]
R. Zalacain, R. Celis.
Antibioterapia en la agudización de la EPOC: ¿sí o no?.
Arch Bronconeumol, 30 (1994), pp. 5-7
[94.]
S. Chodosh.
Treatment of acute exacerbations of chronic bronchitis.
Am J Med, 91 (1991), pp. 87-92
[95.]
J. Martínez.
Antibiotics and vaccination therapy in COPD.
Eur Respir Rev, 7 (1997), pp. 240-242
[96.]
G.J. Huchon, G. Gialdoni-Grassi, P. Leophonte, F. Manresa, T. Schaberg, M. Woodhead.
Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey.
Eur Respir J, 9 (1996), pp. 1.590-1.595
[97.]
M. Miravitlles, C. Mayordomo, L. Sánchez-Agudo, M.T. Artés, S. Pita, J.L. Segú, et al.
Estudio observacional del manejo de las agudizaciones de la EPOC en atención primaria.
Arch Bronconeumol, 32 (1996), pp. 20
[98.]
J. Romero, M. Rubio, O. Corral, S. Pacheco, E. Agudo, J.J. Picazzo.
Estudio de las infecciones respiratorias extrahospitalarias.
Enferm Infecc Microbiol Clin, 15 (1997), pp. 289-298
[99.]
R. Zalacain.
Papel de la infección en la agudización de la EPOC.
Gac Med Bilbao, 90 (1993), pp. 25-27
[100.]
J.A. Smith, P. Redman, M.A. Woodhead.
Audit of antibiotic use in acute exacerbations of chronic obstructive pulmonary disease.
Thorax, 52 (1997), pp. 25
[101.]
P.C. Elmes, C.M. Fletcher, A.C. Dutton.
Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis.
Br Med, 2 (1957), pp. 1.272-1.275
[102.]
D.G. Berry, J. Fry, C.P. Hindley, J.M. Hodsen, E.J. Horder, J.P. Horder, et al.
Exacerbations of chronic bronchitis treatment with oxytetracycline.
[103.]
P.C. Elmes, T.K.C. King, J.H.M. Langlands, J.A. Mackay, W.F.M. Wallace, O.L. Wade, et al.
Value of ampicillin in the hospital treatment of exacerbations of chronic bronchitis.
Br Med J, 2 (1965), pp. 904-908
[104.]
E.S. Petersen, V. Esmann, P. Honche, C. Munkner.
A controlled study of the effect of treatment on chronic bronchitis: an evaluation using pulmonary function tests.
Acta Med Scand, 182 (1967), pp. 293-305
[105.]
A. Pimes, H. Raafat, K. Pucinsky, J.S.B. Greenfel, M.E. Solari.
Antibiotic regimens in severe and acute purulent exacerbations of chronic bronchitis.
Br Med J, 2 (1968), pp. 735-738
[106.]
A. Pines, H. Raafat, J.S.B. Greenfeld, W.D. Linsell, M.E. Solari.
Antibiotic regimens in moderately ill patients and purulent exacerbations of chronic bronchitis.
Br J Dis Chest, 66 (1972), pp. 107-115
[107.]
F. Manresa, R. Blavia, R. Martín, J. Liñares, B. Rodríguez, R. Verdaguer.
Antibiotics for exacerbations of chronic bronchitis.
Lancet, 2 (1987), pp. 394-395
[108.]
A.F. Jorgensen, J. Coolidge, P.A. Pedersen, K.P. Petersen, S. Waldorff, E. Widding.
Amoxicillin in treatment of acute un complicated exacerbations of chronic bronchitis.
Scand J Prim Health Care, 10 (1992), pp. 7-11
[109.]
A.P.E. Sachs, G.H. Koëter, K.H. Gronier, D. Van der Waaij, J. Schiphuis, M. Meyboom-de Jong.
Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with obstructive pulmonary disease.
Thorax, 50 (1995), pp. 758-763
[110.]
S. Saint, S. Bent, E. Vittinghoff, D. Grady.
Antibiotics in chronic obstructive pulmonary disease. A meta-analysis.
JAMA, 273 (1995), pp. 957-960
[111.]
A.L. Davis, E.J. Grobow, R. Tompsett, J.H. McClement.
Bacterial infection and some effects of chemoprophylaxis in chronic pulmonary emphysema, I: Chemoprophylaxis with intermitent tetracycline.
Am J Med, 2 (1961), pp. 985-986
[112.]
A. Pines.
Controlled trials of a sulphonamide given weekiy to prevent exacerbations of chronic bronchitis.
Br Med J, 3 (1967), pp. 202-204
[113.]
G.B. Toews.
Use of antibiotics in patients with chronic obstructive pulmonary disease.
Semin Respir Med, 8 (1986), pp. 165-170
[114.]
P.H. Rothbarth, B.M. Kempen, M.J. Sprenger.
Sense and nonsense of influenza vaccination in asthma and chronic obstructive lung disease.
Am J Respir Crit Care Med, 151 (1995), pp. 1.682-1.685
[115.]
G.T. Ferguson, R.M. Cherniak.
Management of chronic obstructive pulmonary disease.
N Engl J Med, 328 (1993), pp. 1.017-1.022
[116.]
P. Venge, B. Pendersen, L. Kakansson, R. Hällgren, G. Lindblad, R. Dhal.
Subcutaneous administration of hialuronan reduces the humber of infectious exacerbations in patients with chronic bronchitis.
Am J Respir Crir Care Med, 153 (1996), pp. 312-316
[117.]
J.P. Collet, S. Saphiro, P. Ernst, P. Renzi, A. Ducruet, A. Robinson, et al.
Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 156 (1997), pp. 1.719-1.724
[118.]
N.R. Anthonisen.
OM-85 BV for COPD.
Am J Respir Crit Care Med, 156 (1997), pp. 1.713-1.714
Copyright © 1998. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?